NYSE : GMED
Globus Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 78.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.48B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 10.76B |
| Enterprise Value | 10.03B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 111.83M |
| Shares Outstanding | 134.26M |
| Shares Change (YoY) | -1.18% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 17.18% |
| Owned by Institutions (%) | 91.90% |
| Float | 110.92M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.50 |
| Forward PE | 15.64 |
| PS Ratio | 3.38 |
| Forward PS | 3.24 |
| PB Ratio | 2.20 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | 14.09 |
| P/OCF Ratio | 11.69 |
| PEG Ratio | 1.17 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 18.52 |
| EV / Sales | 3.15 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 13.58 |
| EV / FCF | 13.12 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.62 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.81% |
| Return on Assets (ROA) | 8.74% |
| Return on Invested Capital (ROIC) | 13.93% |
| Return on Capital Employed (ROCE) | 14.58% |
| Weighted Average Cost of Capital (WACC) | 9.43% |
| Revenue Per Employee | $524,156 |
| Profits Per Employee | $89,239 |
| Employee Count | 6,000 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.23 |
Taxes
| Measure | Value |
|---|
| Income Tax | 124.69M |
| Effective Tax Rate | 18.89% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +32.02% |
| 50-Day Moving Average | 77.47 |
| 200-Day Moving Average | 83.43 |
| Relative Strength Index (RSI) | 53.34 |
| Average Volume (20 Days) | 1,261,775 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.19M |
| Short Previous Month | 6.77M |
| Short % of Shares Out | 6.10% |
| Short % of Float | 7.38% |
| Short Ratio (days to cover) | 5.17 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.14B |
| Gross Profit | 2.17B |
| Operating Income | 730.32M |
| Pretax Income | 660.12M |
| Net Income | 535.43M |
| EBITDA | 1.01B |
| EBIT | 730.32M |
| Earnings Per Share (EPS) | $3.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 595.14M |
| Total Debt | 111.91M |
| Net Cash | 728.59M |
| Net Cash Per Share | $5.43 |
| Equity (Book Value) | 4.77B |
| Book Value Per Share | 35.52 |
| Working Capital | 1.74B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 910.39M |
| Capital Expenditures | -154.80M |
| Depreciation & Amortization | 279.98M |
| Net Borrowing | n/a |
| Free Cash Flow | 755.59M |
| FCF Per Share | $5.63 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.98% |
| Operating Margin | 23.22% |
| Pretax Margin | 20.99% |
| Profit Margin | 17.03% |
| EBITDA Margin | 32.12% |
| EBIT Margin | 23.22% |
| FCF Margin | 24.03% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.18% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 4.88% |
| FCF Yield | 7.10% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $100.92 |
| Price Target Difference | 25.93% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 6.89% |
| EPS Growth Forecast (3Y) | 13.80% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 10.42 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |